Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None USD 0.00(0%)
Last update at 2026-11-20T21:07:42.452406Z
Market Cap
56.70M

Momentum Score

…

Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
8.91
Low
22.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Goodness Growth Holdings Inc is an OTCQX-listed holding company with limited public disclosure, so its core operations and portfolio are not clearly documented in widely available filings. Long-term prospects likely hinge on the performance of its underlying assets and successful portfolio execution, which could appeal to investors if transparency and scale improve.
Primary risks are limited transparency and low OTC liquidity, concentration and execution risk in underlying assets, and exposure to regulatory and financing uncertainty.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
93.13M
Revenue Per Share
0.67
Gross Profit TTM
19.80M
Debt / Equity
-
ROE
-1890.77%
Net Debt
51.61M
ROCE
1.62%
Diluted EPS TTM
-0.17

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -39.91M -16.89M -17.82M -36.56M -29.57M
Net income -68.11M -28.01M -25.55M -42.46M -33.69M
Selling general administrative 99.85M 31.69M 32.38M 36.52M 38.84M
Gross profit 127.10M 50.77M 44.10M 30.91M 19.80M
Reconciled depreciation 21.96M 3.36M 3.60M 1.33M 1.44M
Ebit - - - - -18.99M
Ebitda - - - -12.64M -17.55M
Non operating income net other - - - - 1.49M
Operating income 10.16M 18.07M 10.58M -6.94M -20.48M
Other operating expenses - - - - 4.08M
Interest expense 30.25M 31.19M 31.26M 22.59M 10.58M
Tax provision 28.20M 11.11M 7.72M 5.89M 4.12M
Net interest income -30.25M -31.19M -31.26M -22.59M -10.58M
Income tax expense - - - - 5.46M
Total revenue 268.77M 99.38M 88.13M 74.63M 54.45M
Total operating expenses 258.61M 81.32M 77.55M 81.57M 40.28M
Cost of revenue 141.67M 48.61M 44.03M 43.72M 32.01M
Total other income expense net -19.82M -3.77M 2.86M -7.03M 1.49M
Net income from continuing ops -68.11M -28.01M -25.55M -42.46M -35.03M
Net income applicable to common shares - - - - -33.69M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 817.15M 278.86M 183.26M 159.16M 166.97M
Intangible assets 117.47M 7.90M 8.72M 8.78M 10.18M
Other current assets - - - - 1.56M
Total liab 509.73M 223.30M 199.31M 155.72M 123.96M
Total stockholder equity 307.42M 55.56M -16.04M 3.44M 43.01M
Other current liab 0.17M 89.39M 88.33M 1.32M 1.60M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -299.55M -231.44M -203.43M -177.88M -135.42M
Good will 87.53M 0.00M 0.00M 0.18M 0.18M
Other assets - - - - 6.96M
Cash 102.23M 91.60M 15.96M 15.15M 15.16M
Total current liabilities 191.53M 135.47M 179.47M 29.71M 16.41M
Net debt 51.61M - 53.40M 42.88M 12.17M
Short long term debt 17.59M 0.90M 60.22M 11.78M -
Property plant equipment - - - - 108.00M
Total current assets 305.11M 230.37M 148.85M 46.73M 41.64M
Long term investments 6.00M 0.00M - - 3.75M
Net tangible assets - - - - 32.64M
Short term investments 1.02M 0.00M - - -
Net receivables 12.67M 2.87M 2.26M 1.42M 4.50M
Long term debt 136.24M 71.30M 9.14M 46.25M 27.33M
Inventory 59.97M 21.67M 19.29M 20.51M 20.42M
Accounts payable 18.87M 2.30M 1.77M 1.91M 14.81M
Retained earnings total equity - - - - -135.42M
Non currrent assets other - - - - 109.72M
Non current assets total 512.04M 48.49M 34.41M 112.43M 1.50M
Capital lease obligations 149.86M 17.89M 11.43M 81.44M 81.83M
Long term debt total - - - - 27.33M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -8.13M -3.48M -5.62M 1.15M
Change to liabilities - - - - 2.65M
Total cashflows from investing activities - - - - -7.21M
Net borrowings 18.26M 13.09M 5.26M - 26.15M
Total cash from financing activities 18.42M 94.01M 5.26M 23.68M 25.78M
Change to operating activities - - - - 0.13M
Net income -68.11M -28.01M -25.55M -42.46M -33.69M
Change in cash 30.89M 75.64M 0.82M -0.01M -11.95M
Begin period cash flow 91.60M 15.96M 15.15M 15.16M 27.11M
End period cash flow 122.49M 91.60M 15.96M 15.15M 15.16M
Total cash from operating activities 3.71M -10.23M -0.97M -18.07M -30.52M
Issuance of capital stock 0.00M 80.83M 0.00M - 0.00M
Depreciation 21.96M 3.36M 3.60M 1.33M 3.37M
Other cashflows from investing activities - - - - 14.82M
Change to inventory -8.70M -2.39M -1.82M -3.99M -10.35M
Change to account receivables -6.06M -1.03M 1.45M 0.23M -3.49M
Sale purchase of stock - - - - 1.21M
Other cashflows from financing activities - - - - -1.58M
Change to netincome - - - - 4.80M
Capital expenditures 29.82M 11.69M 6.05M 5.56M 23.18M
Change receivables - - - - -3.49M
Cash flows other operating - - - - 6.19M
Cash and cash equivalents changes - - - - -11.95M
Change in working capital 1.80M 5.10M 2.30M -4.72M -11.05M
Stock based compensation 12.95M 3.54M 4.16M 2.89M 5.18M
Other non cash items 9.21M 5.75M 9.88M 16.83M 10.67M
Free cash flow -26.11M -21.93M -7.02M -23.63M -48.56M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

Goodness Growth Holdings Inc

Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.

207 South Ninth Street, Minneapolis, MN, United States, 55402

612 999 1606

385

Name Title Year Born
Dr. Kyle E. Kingsley M.D. Founder, Chairman & CEO 1975
Mr. Joshua Nathaniel Rosen Interim Pres & Director 1973
Mr. John A. Heller Chief Financial Officer 1969
Mr. Eric Greenbaum J.D. Chief Scientific Officer 1979
Ms. Amber H. Shimpa Chief Admin. Officer & Director 1979
Mr. Sam Gibbons VP of Investor Relations NA
Mr. J. Michael Schroeder Chief Compliance Officer, Company Sec. & Gen. Counsel 1967
Mr. Albert Zakes VP of Corp. Communications NA
Mr. Harris Rabin Chief Marketing Officer 1975
Dr. Stephen M. Dahmer M.D. Chief Medical Officer 1975

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…